Retrospective Study on the Use of CEFALY® Device During Migraine Attacks
NCT02616978 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 807
Last updated 2017-05-08
Summary
This is an Internet survey to collect data on the use of the Cefaly device to treat migraine attacks in regular Cefaly users.
Conditions
Sponsors & Collaborators
-
Cefaly Technology
lead INDUSTRY
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-11-30
- Primary Completion
- 2015-12-31
- Completion
- 2015-12-31
More Related Trials
-
Occipital Transcutaneous Stimulation in Chronic Migraine
NCT02307071 ·Status: UNKNOWN ·Phase: PHASE4
-
A PIVOTAL STUDY EVALUATING SAFETY AND EFFICACY OF THE SHIRATRONICS MIGRAINE THERAPY SYSTEM
NCT06167655 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Clinical Experience With Transcutaneous Supraorbital Nerve Stimulation in Refractory Migraine
NCT03125525 ·Status: COMPLETED
-
A Safety Study of Galcanezumab in Participants With Migraine, With or Without Aura
NCT02614287 ·Status: COMPLETED ·Phase: PHASE3
-
Repetitive Transcranial Magnetic Stimulation in Treatment and Prophylaxis of Chronic Migraine in Patients With no Prophylactic Treatment for the Last 3 Months
NCT06461767 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
NCT02614261 ·Status: COMPLETED ·Phase: PHASE3
-
Nutritional Intervention in Migraine
NCT02703129 ·Status: COMPLETED ·Phase: NA
-
Cranial Electrotherapy Stimulation in the Treatment of Migraine Headaches
NCT01265797 ·Status: COMPLETED ·Phase: NA
-
mBrain-21 : a Three-month Study on Context-awareness, Physiological Monitoring, and Machine Learning in Migraine and Cluster Headache
NCT04983186 ·Status: COMPLETED ·Phase: NA
-
A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine
NCT04616326 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Neuro-Complex & Multi Supplements for Migraine Prevention
NCT07015411 ·Status: RECRUITING ·Phase: NA
-
MigraineManager: An Individualized Self-Management Tool for Adolescents With Migraine
NCT03157739 ·Status: COMPLETED ·Phase: NA
-
Suppressive Functions of Regulatory T Cells in Migraine
NCT07067112 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Cabergoline as a Preventive Treatment for Chronic Migraine
NCT05525611 ·Status: COMPLETED ·Phase: NA
-
A Study of LY2951742 (Galcanezumab) in Japanese Participants With Migraine
NCT02959190 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of OnabotulinumtoxinA in Migraine
NCT04578782 ·Status: COMPLETED ·Phase: PHASE2
-
Home-based Biofeedback for the Prevention of Migraine
NCT05616741 ·Status: COMPLETED ·Phase: NA
-
PArtial REbreathing for Migraine With Aura 1
NCT05546385 ·Status: TERMINATED ·Phase: NA
-
A Retrospective Study to Evaluate the Effectiveness and Benefit of onabotulinumtoxinA in Patients With Chronic Migraines
NCT01749410 ·Status: COMPLETED
-
Post-marketing Clinical Follow-up for Long-term Use of Intranasal Kinetic Oscillation in Subjects With Chronic Migraine
NCT05843721 ·Status: TERMINATED ·Phase: NA
-
Cluster Headache Treatment Survey
NCT06011811 ·Status: COMPLETED
-
Greater Occipital Nerve (GON) Block Effectivity in the Treatment of Chronic Migraine: 6 Months Follow up
NCT02578719 ·Status: WITHDRAWN ·Phase: PHASE4
-
A Phase III Trial of e-TNS for the Acute Treatment of Migraine
NCT03465904 ·Status: COMPLETED ·Phase: NA
-
Duration of Benefit for OnabotulinumtoxinA in Treatment of Chronic Migraine
NCT02037425 ·Status: COMPLETED ·Phase: PHASE4
-
Cerebri Biofeedback Feasibility Trial
NCT05454319 ·Status: COMPLETED ·Phase: NA